Featured in Hidradenitis Suppurativa
Latest Hidradenitis Suppurativa Videos
Hidradenitis Suppurativa
What Four Years Can Tell Us About Treating Moderate to Severe HS
Featuring Nicholas Brownstone, MD
Featured CME on Hidradenitis Suppurativa

0.5 Credit
Click to save this course
Hidradenitis Suppurativa
CME
Hot Off the Press: Intervening Early and Optimizing Outcomes in Hidradenitis Suppurativa
Release Date
December 11, 2025

0.5 Credit
Click to save this course
Hidradenitis Suppurativa
CME
DermInsider - VGR Session 14
Hidradenitis Suppurativa: Expert Answers to Your Toughest Questions
Release Date
November 19, 2025

0.5 Credit
Click to save this course
Hidradenitis Suppurativa
CME
Tackling Hidradenitis Suppurativa: Exploring Current and Emerging Therapies
Release Date
July 17, 2025

0.5 Credit
Click to save this course
Hidradenitis Suppurativa
CME
Getting a Handle of Hidradenitis Suppurativa Through Holistic Management
Release Date
April 11, 2025
Hidradenitis Suppurativa Episodes to Explore
Episode 2
Another Cup of Tea with Dr. D? Part 2: Closing the Loop on HS
In Part Two of the Tea with Dr. D premiere, James Q. Del Rosso, DO, returns with Lauren Lam, MD, a Canadian dermatologist...
Episode 1
Solving The Puzzle of Hidradenitis Suppurativa: Pulling All the Pieces Together for Each Patient
In this premiere episode of Tea with Dr. D, James Q. Del Rosso, DO, welcomes Lauren Lam, MD, a Canadian dermatologist with...
Hidradenitis Suppurativa News & Research
Four-Year Efficacy and Safety Of Continuous Secukinumab in HS: SUNSHINE/SUNRISE Core and Extension Trials
Sponsored by Novartis Medical Affairs | December 30, 2025
DISCLAIMER: The content provided herein is for your background and educational purposes only and may...
By Authors: Martina L. Porter, Christos C. Zouboulis, Falk G. Bechara, Alice B. Gottlieb, Ziad Reguiaï, Valeria Jordan M., Betrand Paguet, Artem Zharkov, Vipin N., Alexa B. Kimball | | December 31, 2025
Early Treatment Initiation With Secukinumab: Insights From the SUNSHINE/SUNRISE Core Trials
Sponsored by Novartis Medical Affairs | December 30, 2025
LIMITATIONS: The analyses for this poster were exploratory, and no statistical testing was applied.
DISCLAIMER:...
By Authors: Amit Garg, Christopher J. Sayed, Martina L. Porter, Haley B. Naik, Hebing Wang, Alexis Shew, Valeria Jordan M., John R. Ingram, Antonio Martorell | | December 31, 2025
Causal Effect Suggested for BMI, IBD on Hidradenitis Suppurativa
Mendelian randomization analyses support effect of BMI and IBD, with no signs of pleiotropy
By Dermsquared Editorial Team | | December 22, 2025